Dr. Hogrefe graduated from the University of Dayton (Ohio) with a Bachelor of Technology degree which was followed by a 2 year commitment at the US Army’s Walter Reed Army Institute of Research in the Dengue Vaccine Laboratory in Washington DC. He received his Ph.D. degree in Experimental Pathology with an emphasis on tumor immunology from Case Western Reserve University, Cleveland, Ohio. Following his graduate work at Case Western Reserve University, he established the Immunopathology Laboratory at St. Luke’s Hospital in Cleveland as the Associate Director of Immunopathology and also became a Diplomate of the American Board of Medical Laboratory Immunology (ABMLI).
In 1989 Wayne moved to the Microbiology Reference Laboratory (MRL) in Cypress, CA as the Chief of Clinical Immunology and established MRL’s first clinical immunology laboratory. Soon thereafter MRL became Focus Diagnostics, and over the next 18 years Wayne took on positions of increasing managerial responsibilities, over that time Wayne transitioned to the following Director roles at Focus Diagnostics: Clinical Immunology, Laboratory Operations, Research & Development, IVD Product Development, Licensing, and Scientific Affairs & Technical Services. In 2007 Wayne moved to the Vice President position in the Focus Diagnostics Clinical Trials business unit. In 2015 the Focus Diagnostics Clinical Trials business unit moved to a new Quest – QuintilesIMS joint venture, Q2 Solutions, which is currently the Q2 Solutions Vaccines business unit and the company’s Center of Excellence for Vaccines.
Over the last 30 years Wayne’s technical interest has been related to infectious disease, serology, and immune response monitoring with an emphasis on emerging diseases, vector-borne diseases, and novel vaccines moving into clinical practice.